Christel Celeste Bastida - Publications

Affiliations: 
University of Texas at Austin, Austin, Texas, U.S.A. 
Area:
Neuroendocrinology, Cancer, Phase I Clinical Trials, Reconstructive Surgery, Patient-reported outcomes

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Mendoza TR, Wang XS, Williams LA, Shi Q, Vichaya EG, Dougherty PM, Thomas SK, Yucel E, Bastida CC, Woodruff JF, Cleeland CS. Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale Journal of Pain. DOI: 10.1016/j.jpain.2015.07.002  0.68
2014 Bastida CC, Puga F, Gonzalez-Lima F, Jennings KJ, Wommack JC, Delville Y. Chronic social stress in puberty alters appetitive male sexual behavior and neural metabolic activity. Hormones and Behavior. 66: 220-7. PMID 24852486 DOI: 10.1016/j.yhbeh.2014.05.002  0.68
2014 Falchook GS, Lippman SM, Bastida CC, Kurzrock R. Human epidermal receptor 2-amplified salivary duct carcinoma: regression with dual human epidermal receptor 2 inhibition and anti-vascular endothelial growth factor combination treatment. Head & Neck. 36: E25-7. PMID 23852769 DOI: 10.1002/hed.23429  0.68
2013 Falchook GS, Moulder SL, Wheler JJ, Jiang Y, Bastida CC, Kurzrock R. Dual HER2 inhibition in combination with anti-VEGF treatment is active in heavily pretreated HER2-positive breast cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 24: 3004-11. PMID 24158411 DOI: 10.1093/annonc/mdt395  0.68
2013 Falchook GS, Trent JC, Heinrich MC, Beadling C, Patterson J, Bastida CC, Blackman SC, Kurzrock R. BRAF mutant gastrointestinal stromal tumor: first report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance. Oncotarget. 4: 310-5. PMID 23470635  0.68
2013 Falchook GS, Janku F, Tsao AS, Bastida CC, Stewart DJ, Kurzrock R. Non-small-cell lung cancer with HER2 exon 20 mutation: regression with dual HER2 inhibition and anti-VEGF combination treatment. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 8: e19-20. PMID 23328556 DOI: 10.1097/JTO.0b013e31827ce38e  0.68
2012 Arendt DH, Smith JP, Bastida CC, Prasad MS, Oliver KD, Eyster KM, Summers TR, Delville Y, Summers CH. Contrasting hippocampal and amygdalar expression of genes related to neural plasticity during escape from social aggression. Physiology & Behavior. 107: 670-9. PMID 22450262 DOI: 10.1016/j.physbeh.2012.03.005  0.68
2009 Bastida CC, Puga F, Delville Y. Risk assessment and avoidance in juvenile golden hamsters exposed to repeated stress. Hormones and Behavior. 55: 158-62. PMID 18948107 DOI: 10.1016/j.yhbeh.2008.09.009  0.68
2007 Puga F, Barrett DW, Bastida CC, Gonzalez-Lima F. Functional networks underlying latent inhibition learning in the mouse brain. Neuroimage. 38: 171-83. PMID 17703956 DOI: 10.1016/j.neuroimage.2007.06.031  0.68
2006 Taravosh-Lahn K, Bastida C, Delville Y. Differential responsiveness to fluoxetine during puberty. Behavioral Neuroscience. 120: 1084-92. PMID 17014259 DOI: 10.1037/0735-7044.120.5.1084  0.68
Show low-probability matches.